Home/NextCure/Lieping Chen
LC

Lieping Chen

Co-Founder and Scientific Advisor

NextCure

Roles

Co-Founder and Scientific AdvisoratNextCure
Scientific FounderatDynamiCure

Therapeutic Areas

NextCure Pipeline

DrugIndicationPhase
NC318Non-small cell lung cancer (NSCLC), ovarian cancer, other solid tumorsPhase 1/2
NC410Solid tumors (e.g., colorectal, ovarian, pancreatic)Phase 1/2
NC525Acute Myeloid Leukemia (AML)Preclinical